When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TEVA - Teva Pharmaceutical's Ice-Cube Business Model
Teva Pharmaceutical Industries Limited American Depositary Shares
European authorities' antitrust probe will likely push the company to change its marketing practices, which allegedly hindered competitors from introducing generic versions of Teva's Copaxone®.
With the recent commercialization of Belrapzo®, a superior substitute for Teva's Bendeka®, sales from this drug will probably suffer in the coming quarters.
Increased debt combined with competitive dynamics in Teva's branded and generic segments, and a weak balance sheet leads us to conclude that the company will not rush to reinstate dividends.